1. Little warning of pentamidine-induced hypoglycaemia

   Newsletter Article 27 January 2013 Pages: 1 - 1

2. Tryptophan-related disorders may be caused by a buildup of metabolites

   Newsletter Article 27 January 2013 Pages: 1 - 1

3. Concern over the electrolyte imbalance potential of indapamide and ‘Moduretic’

   Newsletter Article 27 January 2013 Pages: 1 - 1

4. Complications of inhaled corticosteroid therapy for asthma

   Newsletter Article 27 January 2013 Pages: 2 - 4

5. ADRs related to currently available antidepressants

   Newsletter Article 27 January 2013 Pages: 4 - 5

6. Amiodarone

   Newsletter Article 27 January 2013 Pages: 5 - 5

7. Aminoglycosides

   Newsletter Article 27 January 2013 Pages: 5 - 5

8. Antiarrhythmics

   Newsletter Article 27 January 2013 Pages: 5 - 5

9. Antibacterials

   Newsletter Article 27 January 2013 Pages: 5 - 6

10. Anticonvulsants

    Newsletter Article 27 January 2013 Pages: 6 - 6

11. Antineoplastics

    Newsletter Article 27 January 2013 Pages: 6 - 6

12. Antipsychotics

    Newsletter Article 27 January 2013 Pages: 6 - 6

13. Betaxolol/levobunolol/timolol

    Newsletter Article 27 January 2013 Pages: 6 - 6

14. Chlorpropamide/tolazamide

    Newsletter Article 27 January 2013 Pages: 6 - 6

15. Cisplatin

    Newsletter Article 27 January 2013 Pages: 6 - 7

16. Cocaine abuse

    Newsletter Article 27 January 2013 Pages: 7 - 7

17. Contrast media

    Newsletter Article 27 January 2013 Pages: 7 - 7

18. Corticosteroids

    Newsletter Article 27 January 2013 Pages: 7 - 7

19. Cotrimoxazole

    Newsletter Article 27 January 2013 Pages: 7 - 8

20. Diazepam dependence

    Newsletter Article 27 January 2013 Pages: 8 - 8

21. Diclofenac

    Newsletter Article 27 January 2013 Pages: 8 - 8

22. Doxorubicin/vindesine

    Newsletter Article 27 January 2013 Pages: 8 - 8

23. Enalapril

    Newsletter Article 27 January 2013 Pages: 8 - 9

24. Fluoxetine

    Newsletter Article 27 January 2013 Pages: 9 - 9

25. Fusidic acid

    Newsletter Article 27 January 2013 Pages: 9 - 9

26. Haloperidol withdrawal

    Newsletter Article 27 January 2013 Pages: 9 - 9

27. Heparin

    Newsletter Article 27 January 2013 Pages: 9 - 9

28. Hepatitis B vaccine

    Newsletter Article 27 January 2013 Pages: 9 - 10

29. H2-antagonists see Warfarin interaction

    Newsletter Article 27 January 2013 Pages: 10 - 10

30. Ifosfamide

    Newsletter Article 27 January 2013 Pages: 10 - 10

31. Influenza virus vaccine

    Newsletter Article 27 January 2013 Pages: 10 - 10

32. Interferon alpha

    Newsletter Article 27 January 2013 Pages: 10 - 10

33. Interleukin 2

    Newsletter Article 27 January 2013 Pages: 10 - 10

34. Ketoprofen

    Newsletter Article 27 January 2013 Pages: 10 - 10

35. Labetalol overdose

    Newsletter Article 27 January 2013 Pages: 10 - 11

36. Levobunolol see Betaxolol/levobunolol/timolol

    Newsletter Article 27 January 2013 Pages: 11 - 11

37. Levodopa

    Newsletter Article 27 January 2013 Pages: 11 - 11

38. Mesalazine

    Newsletter Article 27 January 2013 Pages: 11 - 11

39. Methotrexate withdrawal

    Newsletter Article 27 January 2013 Pages: 11 - 11

40. Misoprostol

    Newsletter Article 27 January 2013 Pages: 11 - 11

41. Nifedipine see Verapamil/nifedipine

    Newsletter Article 27 January 2013 Pages: 11 - 11

42. Pancuronium bromide

    Newsletter Article 27 January 2013 Pages: 11 - 11

43. Phentermine

    Newsletter Article 27 January 2013 Pages: 11 - 11

44. Phytomenadione

    Newsletter Article 27 January 2013 Pages: 11 - 11

45. Propofol/thiopental sodium

    Newsletter Article 27 January 2013 Pages: 11 - 11

46. Pseudoephedrine

    Newsletter Article 27 January 2013 Pages: 11 - 12

47. Pyrimethamine + sulfadoxine

    Newsletter Article 27 January 2013 Pages: 12 - 12

48. Sodium hypochlorite

    Newsletter Article 27 January 2013 Pages: 12 - 12

49. Streptokinase

    Newsletter Article 27 January 2013 Pages: 12 - 12

50. Sulfadoxine see Pyrimethamine + sulfadoxine

    Newsletter Article 27 January 2013 Pages: 12 - 12